---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-016105"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2021-07-02T23:59:59+00:00"
generated_at: "2026-06-30T07:48:00.565245+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oncotelic extends note maturity to March 2022, issues 22M warrants, CTO Park resigns

## Summary
- Issued $103,750 convertible promissory note to Geneva Roth Remark Holdings on June 28, 2021.
- Extended maturity of JH Darbie financing notes from June 30, 2021 to March 31, 2022.
- Issued 20M additional Oncotelic warrants to investors and 2M warrants to placement agent J.H. Darbie & Co.
- CTO Chulho Park resigned effective July 1, 2021 due to personal health; will continue as part-time consultant.

## SEC filing metadata
- accession: 0001493152-21-016105
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2021-07-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/0001493152-21-016105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-016105
- JSON: https://secwatch.observer/filing/0001493152-21-016105.json
- Plain text: https://secwatch.observer/filing/0001493152-21-016105.txt

## Key facts
- Executive change
  Chulho Park resigned as Chief Technology Officer at Oncotelic Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Technology Officer
  source text: On July 1, 2021, Chulho Park, Ph. D., provided notice to the Company of his intention to resign as the Chief Technology Officer of the Company, to be effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/0001493152-21-016105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.